| Literature DB >> 25314593 |
Jochen Schneider1, Alexander Hapfelmeier2, Julia Fremd3, Philipp Schenk3, Andreas Obermeier4, Rainer Burgkart4, Stefanie Forkl5, Susanne Feihl5, Nina Wantia5, Bruno Neu3, Monther Bajbouj3, Stefan von Delius3, Roland M Schmid3, Hana Algül3, Andreas Weber3.
Abstract
Bacterial colonization of biliary stents is one of the driving forces behind sludge formation which may result in stent occlusion. Major focus of the study was to analyze the spectrum and number of microorganisms in relation to the indwelling time of stents and the risk factors for sludge formation. 343 stents were sonicated to optimize the bacterial release from the biofilm and identified by matrix-associated laser desorption/ionization-time of flight mass spectrometer (MALDI-TOF). 2283 bacteria were analyzed in total. The most prevalent microorganisms were Enterococcus species (spp.) (504;22%), followed by Klebsiella spp. (218;10%) and Candida spp. (188;8%). Colonization of the stents mainly began with aerobic gram-positive bacteria (43/49;88%) and Candida spp. (25/49;51%), whereas stents with an indwelling time>60 days(d) showed an almost equal colonization rate by aerobic gram-negative (176/184;96%) and aerobic gram-positive bacteria (183/184;99%) and a high proportion of anaerobes (127/184;69%). Compared to stents without sludge, more Clostridium spp. [(P = 0.02; Odds Ratio (OR): 2.4; 95% confidence interval (95%CI): (1.1-4.9)]) and Staphylococcus spp. [(P = 0.03; OR (95%CI): 4.3 (1.1-16.5)] were cultured from stents with sludge. Multivariate analysis revealed a significant relationship between the number of microorganisms [P<0.01; OR (95%CI): 1.3(1.1-1.5)], the indwelling time [P<0.01; 1-15 d vs. 20-59 d: OR (95%CI): 5.6(1.4-22), 1-15 d vs. 60-3087 d: OR (95% CI): 9.5(2.5-35.7)], the presence of sideholes [P<0.01; OR (95%CI): 3.5(1.6-7.9)] and the occurrence of sludge. Stent occlusion was found in 70/343(20%) stents. In 35% of cases, stent occlusion resulted in a cholangitis or cholestasis. In conclusion, microbial colonization of the stents changed with the indwelling time. Sludge was associated with an altered spectrum and an increasing number of microorganisms, a long indwelling time and the presence of sideholes. Interestingly, stent occlusion did not necessarily lead to a symptomatic biliary obstruction.Entities:
Mesh:
Year: 2014 PMID: 25314593 PMCID: PMC4197023 DOI: 10.1371/journal.pone.0110112
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics.
| Number of patients | 130 |
| Median age in years (range) | 67(22–91) |
| Male | 77 |
| Reason for stent therapy | |
|
| 45 |
| -Cholangiocarcinoma | 20 |
| -Pancreas cancer | 14 |
| -Hepatocellular carcinoma | 1 |
| -Liver metastases with intrahepatic biliary obstruction: | |
| -Breast cancer | 1 |
| -Colorectal cancer | 6 |
| -Gastric cancer | 1 |
| -Malignant melanoma | 1 |
| -Lymphoma | 1 |
|
| 80 |
| -Anastomotic stricture after liver transplantation | 7 |
| -Biliary leakage after liver transplantation | 4 |
| -Chronic pancreatitis with extrahepatic bile duct obstruction | 4 |
| -Biliary stricture after cholecystectomy | 8 |
| -Adenoma of the papilla vateri | 1 |
| -Insufficiency of the ductus cysticus after cholecystectomy | 1 |
| -Radiation induced biliary stricture | 2 |
| -Incomplete removal of biliary stones | 47 |
| -Primary sclerosing cholangitis | 2 |
| -Secondary sclerosing cholangitis | 2 |
| -Biloma | 2 |
|
| 5 |
| Total number of biliary stents | 343 |
| Number of biliary stents with sludge | 149 |
| Number of biliary stent with occlusion | 70 |
| Median duration of indwelling time in days (range) | 70 (1–3087) |
| Total number of treatment episodes with stent extraction | 234 |
| Number of treatment episodes with multi-stenting | 90 |
| Number of elective stent extractions | 197 |
Spectrum of microorganisms isolated from the biliary stents.
| Total number of microorganisms | Number of stents isolated from | |
| Number of stents | 343 | |
| Total number of microorganisms | 2283 | |
| Median number of microorganisms (range) | 7(0–14) | |
| Aerobic gram-positive bacteria | 914; 40% | 332; 97% |
|
| 504; 22% | 297; 87% |
| Enterococcus faecium | 126; 6% | 126; 37% |
| Enterococcus faecalis | 223; 10% | 223; 65% |
| Other Enterococcus spp. | 155; 7% | 133; 39% |
|
| 213; 9% | 170; 50% |
| Streptococcus viridans group | 211; 9% | 169; 49% |
| Streptococcus (beta-haemolytic) | 2; <1% | 2; 1% |
|
| 39; 2% | 37; 11% |
| Staphylococcus aureus | 12; 1% | 12; 3% |
| Staphylococcus (coagulase-negative) | 27; 1% | 27; 8% |
|
| 158; 7% | 117; 34% |
| Aerobic gram-negative bacteria | 771; 34% | 297; 87% |
|
| 665; 29% | 279; 81% |
| Escherichia spp. | 182; 8% | 170; 50% |
| Klebsiella spp. | 218; 10% | 180; 52% |
| Citrobacter spp. | 77; 3% | 61; 18% |
| Proteus spp. | 39; 2% | 39; 11% |
| Morganella spp. | 17; 1% | 17; 5% |
| Enterobacter spp. | 112; 5% | 98; 29% |
| Serratia spp. | 1; <1% | 1; <1% |
| Other Enterobacteriaceae | 19; 1% | 19; 6% |
|
| 36; 2% | 36; 10% |
| Pseudomonas spp. | 29; 1% | 29; 8% |
| Stenotrophomonas spp. | 3; <1% | 3; 1% |
| Acinetobacter spp. | 3; <1% | 3; 1% |
| Other non-fermenting bacteria | 1; <1% | 1; <1% |
|
| 70; 3% | 58; 17% |
| Anaerobes | 409; 18% | 212; 62% |
| Bacteroides spp. | 64; 3% | 50; 15% |
| Prevotella spp. | 149; 7% | 123; 36% |
| Fusobacterium spp. | 19; 1% | 19; 6% |
| Veillonella spp. | 47; 2% | 45; 13% |
| Clostridium spp. | 106; 5% | 98; 29% |
| Propionibacterium spp. | 14; 1% | 14; 4% |
| Other anaerobes | 10; <1% | 10; 3% |
| Candida spp. | 188; 8% | 155; 45% |
| Candida albicans | 84; 4% | 84; 24% |
| Candida tropicalis | 17; 1% | 17; 5% |
| Candida glabrata | 51; 2% | 51; 15% |
| Candida krusei | 3; <1% | 3; 1% |
| Candida norvegensis | 1; <1% | 1; <1% |
| Candida dublinensis | 2; <1% | 2; 1% |
| Candida robusta | 1; <1% | 1; <1% |
| other candida spp. | 29; 1% | 28; 8% |
| Magnusiomyces spp. | 1; <1% | 1; <1% |
The spectrum and the number of microorganisms in relation to the indwelling time of the stents.
| Number of microorganisms isolated from stents, with an indwelling time (1–15)d | Number of microorganisms isolated from stents, with an indwelling time (20–59)d | Number of microorganisms isolated from stents, with an indwelling time (60–3087)d | Number of stents isolated from, with an indwelling time (1–15)d | Number of stents isolated from, with an indwelling time (20–59)d | Number of stents isolated from, with an indwelling time (60–3087)d | P-Value | |
| Number of stents | 49 | 100 | 184 | ||||
| Total number (microorganisms) | 178 | 660 | 1386 | ||||
| Median number (microorganisms) (range) | 3(0–10) | 6(2–13) | 8(2–14) | ||||
| Aerobic gram-positive bacteria | 92; 52% | 277; 42% | 524; 38% | 43; 88% | 98; 98% | 183; 99% | P<0.01 |
|
| 28; 16% | 162; 25% | 300; 22% | 24; 49% | 90; 90% | 175; 95% | P<0.01 |
| Enterococcus faecium | 16; 9% | 46; 7% | 61; 4% | 16; 33% | 46; 46% | 61; 33% | P = 0.08 |
| Enterococcus faecalis | 6; 3% | 69; 10% | 142; 10% | 6; 12% | 69; 69% | 142; 77% | P<0.01 |
| Other Enterococcus spp. | 6; 3% | 47; 7% | 97; 7% | 6; 12% | 37; 37% | 85; 46% | P<0.01 |
|
| 29; 16% | 59; 9% | 119; 9% | 21; 43% | 47; 47% | 98; 53% | P = 0.34 |
| Streptococcus viridans group | 29; 16% | 58; 9% | 118; 9% | 21; 43% | 46; 46% | 98; 53% | P = 0.30 |
| Streptococcus (Beta-haemolytic) | 0 | 1; <1% | 1; <1% | 0 | 1; 1% | 1; 1% | P = 1.00 |
|
| 12; 7% | 8; 1% | 18; 1% | 10; 20% | 8; 8% | 18; 10% | P = 0.06 |
| Staphylococcus aureus | 1; 1% | 3; <1% | 7; 1% | 1; 2% | 3; 3% | 7; 4% | P = 1.00 |
| Staphylococcus coagulase-negative | 11; 6% | 5; 1% | 11; 1% | 9; 18% | 5; 5% | 11; 6% | P = 0.02 |
|
| 23; 13% | 48; 7% | 87; 6% | 18; 37% | 32; 32% | 67; 36% | - |
| Aerobic gram-negative bacteria | 35; 20% | 204; 31% | 511; 37% | 22; 45% | 90; 90% | 176; 96% | P<0.01 |
|
| 26; 15% | 165; 25% | 453; 33% | 17; 35% | 82; 82% | 171; 93% | P<0.01 |
| Escherichia spp. | 8; 4% | 44; 7% | 122; 9% | 8; 16% | 43; 43% | 112; 61% | P<0.01 |
| Klebsiella spp. | 5; 3% | 54; 8% | 154; 11% | 4; 8% | 48; 48% | 123; 67% | P<0.01 |
| Citrobacter spp. | 2; 1% | 23; 3% | 51; 4% | 2; 4% | 18; 18% | 40; 22% | P = 0.02 |
| Proteus spp. | 0(0) | 8; 1% | 29; 2% | 0 | 8; 8% | 29; 16% | P<0.01 |
| Morganella spp. | 0(0) | 4; 1% | 13; 1% | 0 | 4; 4% | 13; 7% | P = 0.12 |
| Enterobacter spp. | 11; 6% | 27; 4% | 69; 5% | 8; 16% | 23; 23% | 62; 34% | P = 0.02 |
| Serratia spp. | 0(0) | 0(0) | 1; <1% | 0 | 0 | 1; 1% | P = 1.00 |
| Other Enterobacteriaceae | 0(0) | 5; 1% | 14; 1% | 0 | 5; 5% | 14; 8% | - |
|
| 4; 2% | 15; 2% | 17; 1% | 4: 8% | 15; 15% | 17; 9% | P = 0.27 |
| Pseudomonas spp. | 1; 1% | 13; 2% | 15; 1% | 1; 2% | 13; 13% | 15; 8% | P = 0.07 |
| Stenotrophomonas spp. | 0(0) | 2; <1% | 1; <1% | 0 | 2; 2% | 1; 1% | P = 0.56 |
| Acinetobacter spp. | 2; 1% | 0(0) | 1; <1% | 2; 4% | 0 | 1; 1% | P = 0.08 |
| Other non-fermenting bacteria | 1; 1% | 0(0) | 0 | 1; 2% | 0 | 0 | - |
|
| 5; 3% | 24; 4% | 41; 3% | 3; 6% | 20; 20% | 35; 19% | - |
| Anaerobes | 18; 10% | 125; 19% | 254; 18% | 12; 24% | 67; 67% | 127; 69% | P<0.01 |
| Bacteroides spp. | 2; 1% | 18; 3% | 44; 3% | 2; 4% | 13; 13% | 35; 19% | P = 0.03 |
| Prevotella spp. | 10; 6% | 48; 7% | 87; 6% | 8; 16% | 39; 39% | 73; 40% | P = 0.01 |
| Fusobacterium spp. | 0(0) | 2; <1% | 15; 1% | 0 | 2; 2% | 15; 8% | P = 0.02 |
| Veillonella spp. | 5; 3% | 21; 3% | 18; 1% | 5; 10% | 21; 21% | 17; 9% | P = 0.08 |
| Clostridium spp. | 1; 1% | 28; 4% | 75; 5% | 1; 2% | 26; 26% | 69; 38% | P<0.01 |
| Propionibacterium spp. | 0(0) | 5; 1% | 8; 1% | 0 | 5; 5% | 8; 4% | P = 0.30 |
| Other anaerobes | 0(0) | 3; <1% | 7; 1% | 0 | 3; 3% | 7; 4% | - |
| Candida spp. | 33; 19% | 54; 8% | 96; 7% | 25; 51% | 42; 42% | 83; 45% | P = 0.58 |
| Candida albicans | 17; 10% | 27; 4% | 36; 3% | 17; 35% | 27; 27% | 36; 20% | P = 0.62 |
| Candida tropicalis | 1; 1% | 7; 1% | 9; 1% | 1; 2% | 7; 7% | 9; 5% | P = 0.48 |
| Candida glabrata | 5; 3% | 12; 2% | 33; 2% | 5; 10% | 12; 12% | 33; 18% | P = 0.24 |
| Candida krusei | 0 | 2; <1% | 1; <1% | 0 | 2; 2% | 1; 1% | P = 0.56 |
| Candida norvegensis | 1; 1% | 0 | 0 | 1; 2% | 0 | 0 | P = 0.15 |
| Candida dublinensis | 0 | 1; <1% | 1; <1% | 0 | 1; 1% | 1; 1% | P = 1.00 |
| Candida robusta | 0 | 1; <1% | 0 | 0 | 1; 1% | 0 | P = 0.45 |
| Other Candida spp. | 9; 5% | 4; 1% | 16; 1% | 8; 16% | 4; 4% | 16; 9% | - |
| Magnusiomyces | 0 | 0 | 1; <1% | 0 | 0 | 1; 1% | P = 1.00 |
*8 stents could not be included to this analysis due to an unknown indwelling time.
Comparison of the spectrum of microorganisms between stents with and without sludge.
|
|
|
|
| UnivariateAnalysis | MultivariateAnalysisP-ValueOdds ratio (95% CI) | |
| Number of microorganisms | 831(100%) | 555(100%) | - | - | - | - |
| Number of stents | - | - | 98(100%) | 86(100%) | - | - |
| Median indwelling time in days | 93 | 93 | 93 | 93 | - | - |
| - | ||||||
| Aerobic gram-positive bacteria | 317; 38% | 207; 37% | 98; 100% | 85; 99% | P = 0.47 | - |
|
| 176; 21% | 124; 22% | 95; 97% | 80; 93% | P = 0.30 | - |
| Enterococcus faecium | 34; 4% | 27; 5% | 34; 35% | 27; 31% | P = 0.64 | - |
| Enterococcus faecalis | 78; 9% | 64; 12% | 78; 80% | 64; 74% | P = 0.40 | - |
| Other Enterococcus spp. | 64; 8% | 33; 6% | 55; 56% | 30; 35% | - | - |
| - | ||||||
|
| 74; 9% | 45; 8% | 60; 61% | 38; 44% | P = 0.02 | P = 0.16; 1.6(0.8–3.1) |
| Streptococcus viridans group | 74; 9% | 44; 8% | 60; 61% | 38; 44% | P = 0.02 | - |
| Streptococcus (Beta-haemolytic) | 0 | 1; <1% | 0 | 1; 1% | P = 0.47 | - |
|
| 15; 2% | 3; 1% | 15; 15% | 3; 3% | P = 0.01 | P = 0.03; 4.3(1.1–16.5) |
| Staphylococcus aureus | 7; 1% | 0 | 7; 7% | 0 | P = 0.02 | - |
| Staphylococcus (coagulase-neg.) | 8; 1% | 3; 1% | 8; 8% | 3; 3% | P = 0.18 | - |
|
| 52; 6% | 35; 6% | 40; 41% | 27; 31% | - | - |
| Aerobic gram-negative bacteria | 302; 36% | 209; 38% | 95; 97% | 81; 94% | P = 0.48 | - |
|
| 260; 31% | 193; 35% | 93; 95% | 78; 91% | P = 0.27 | - |
| Escherichia spp. | 69; 8% | 53; 10% | 65; 66% | 47; 55% | P = 0.11 | - |
| Klebsiella spp. | 91; 11% | 63; 11% | 70; 71% | 53; 62% | P = 0.16 | - |
| Citrobacter spp. | 29; 3% | 22; 4% | 25; 26% | 15; 17% | P = 0.19 | - |
| Proteus spp. | 16; 2% | 13; 2% | 16; 16% | 13; 15% | P = 0.82 | - |
| Morganella spp. | 5; 1% | 8; 1% | 5; 5% | 8; 9% | P = 0.27 | - |
| Enterobacter spp. | 41; 5% | 28; 5% | 36; 37% | 26; 30% | P = 0.35 | - |
| Serratia spp. | 1; <1% | 0 | 1; 1% | 0 | P = 1.00 | - |
| Other Enterobacteriaceae | 8; 1% | 6; 1% | 8; 8% | 6; 7% | - | - |
|
| 10; 1% | 7; 1% | 10; 10% | 7; 8% | P = 0.63 | - |
| Pseudomonas spp. | 8; 1% | 7; 1% | 8; 8% | 7; 8% | P = 1.00 | - |
| Stenotrophomonas spp. | 1; <1% | 0 | 1; 1% | 0 | P = 1.00 | - |
| Acinetobacter spp. | 1; <1% | 0 | 1; 1% | 0 | P = 1.00 | - |
| Other non-fermenting bacteria | 0 | 0 | 0 | 0 | - | - |
|
| 32; 4% | 9; 2% | 27; 28% | 8; 9% | - | - |
| - | ||||||
| Anaerobes | 167; 20% | 87; 16% | 79; 81% | 48; 56% | P<0.01 | - |
| Bacteroides spp. | 30; 4% | 14; 3% | 24; 24% | 11; 13% | P = 0.04 | P = 0.83; 2.2(0.9–5.3) |
| Prevotella spp. | 57; 7% | 30; 5% | 47; 48% | 27; 31% | P = 0.03 | P = 0.44; 1.3(0.6–2.8) |
| Fusobacterium spp. | 12; 1% | 3; 1% | 12; 12% | 3; 3% | P = 0.03 | P = 0.24; 2.3(0.5–9.2) |
| Veillonella spp. | 11; 1% | 7; 1% | 10; 10% | 7; 8% | P = 0.14 | |
| Clostridium spp. | 49; 6% | 26; 5% | 47; 48% | 22; 26% | P = 0.02 | P = 0.02; 2.4(1.1–4.9) |
| Propionibacterium spp. | 7; 1% | 1; <1% | 7; 7% | 1; 1% | P = 0.07 | - |
| Other Anaerobes | 1; <1% | 6; 1% | 1; 1% | 6; 7% | - | - |
| Candida spp. | 44; 5% | 52; 9% | 39; 40% | 44; 51% | P = 0.12 | - |
| - | ||||||
| Candida albicans | 21; 3% | 15; 3% | 21; 21% | 15; 17% | P = 0.50 | - |
| Candida tropicalis | 6; 1% | 3; 1% | 6; 6% | 3; 3% | P = 0.51 | - |
| Candida glabrata | 10; 1% | 23; 4% | 10; 10% | 23; 27% | P = 0.04 | P = 0.10; 0.5(0.2–1.2) |
| Candida krusei | 1; <1% | 0 | 1; 1% | 0 | P = 1.00 | - |
| Candida robusta | 0 | 0 | 0 | 0 | - | - |
| Candida dublinensis | 0 | 1; <1% | 0 | 1; 1% | P = 0.47 | - |
| Other Candida spp. | 6; 1% | 10; 2% | 6; 6% | 10; 12% | - | - |
| Magnusiomyces | 1; <1% | 0 | 1; 1% | 0 | P = 1.00 | - |